INGN
Inogen Inc

1,478
Mkt Cap
$154.2M
Volume
6,452.00
52W High
$11.94
52W Low
$5.48
PE Ratio
-5.66
INGN Fundamentals
Price
$5.84
Prev Close
$5.68
Open
$5.68
50D MA
$6.33
Beta
1.30
Avg. Volume
220,074.35
EPS (Annual)
-$1.52
P/B
0.78
Rev/Employee
$438,257.18
$118.90
Loading...
Loading...
Poll

Earnings Recap

• Reported GAAP EPS of -$0.26 up 36.59% YoY • Reported revenue of $81.72M up 2.05% YoY • Inogen expects full year 2026 reported revenue in the range of $366M to $373M, reflecting approximately 6% growth from 2025 revenue, and anticipates positive Adjusted EBITDA improvement in 2026.

Bullish

Inogen improved operating loss and Adjusted EBITDA through cost reductions and efficiencies. The company introduced new products, launched a patient portal, and announced a strategic collaboration with Yuwell Medical.

Bearish

Inogen's gross margin decreased due to channel mix, and lower U.S. sales and rentals impacted revenue. Q1 2026 revenue is expected flat due to channel mix, reimbursement shifts, and fewer patients.

Latest INGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.